Positive Lymph Nodes at Lymphadenectomy for Prostate Cancer: Where Do We Set the Tiller?

European Urology

Volumn 55, Issue 2, 2009, Pages 271-272

  Thalmann, George N ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

CANCER STAGING; CANCER SURVIVAL; EDITORIAL; HORMONAL THERAPY; HUMAN; LYMPH NODE METASTASIS; LYMPHADENECTOMY; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; PROSTATECTOMY; TUMOR GROWTH;

HUMANS; LYMPH NODE EXCISION; LYMPH NODES; MALE; PATIENT SELECTION; PROSTATIC NEOPLASMS; REPRODUCIBILITY OF RESULTS; SURVIVAL RATE;

EID: 57649176797     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2008.10.039     Document Type: Editorial

References (6)

1. Briganti A., Karnes J.R., Da Pozzo L.F., et al. Two positive nodes represent a significant cut-off value for cancer specific survival in patients with node positive prostate cancer. A new proposal based on a two-institution experience on 703 consecutive N+ patients treated with radical prostatectomy, extended pelvic lymph node dissection and adjuvant therapy. Eur Urol 55 (2009) 261-270
2. Bader P., Burkhard F.C., Markwalder R., and Studer U.E. Disease progression and survival of patients with positive lymph nodes after radical prostatectomy. Is there a chance of cure?. J Urol 169 (2003) 849-854
3. Schumacher M.C., Burkhard F.C., Thalmann G.N., Fleischmann A., and Studer U.E. Good outcome for patients with few lymph node metastases after radical retropubic prostatectomy. Eur Urol 54 (2008) 344-352
4. Fleischmann A., Schobinger S., Markwalder R., et al. Prognostic factors in lymph node metastases of prostatic cancer patients: the size of the metastases but not extranodal extension independently predicts survival. Histopathology 53 (2008) 468-475
5. Weingärtner K., Ramaswamy A., Bittinger A., Gerharz E.W., Vöge D., and Riedmiller H. Anatomical basis for pelvic lymphadenectomy in prostate cancer: results of an autopsy study and implications for the clinic. J Urol 156 (1996) 1969-1971
6. Messing E.M., Manola J., Yao J., et al. Eastern Cooperative Oncology Group study EST 3886. Immediate versus deferred androgen deprivation treatment in patients with node-positive prostate cancer after radical prostatectomy and pelvic lymphadenectomy. Lancet Oncol 7 (2006) 472-479